NCT05410782

Brief Summary

Male factor infertility is a leading cause of primary and secondary infertility. Poor sperm quality is defined as having an abnormal semen analysis \[WHO 2020 - https://www.who.int/publications/i/item/9789240030787\]. The effects of supplements (vitamins, minerals, and anti-oxidants) on improving sperm quality are still debated (https://pubmed.ncbi.nlm.nih.gov/30462179). Taking additional supplements to improve sperm quality represent a modifiable risk-factor that would be an easy intervention for patients struggling with male factor infertility. The life cycle of sperm production is estimated at 3 months, so any intervention would require a 3 month course to see its full effect. The investigators hypothesize that a 90 day course of the "Power Prenatal for Sperm", a male fertility supplement by Bird\&Be (https://birdandbe.com/the-power-prenatal-for-sperm) will improve sperm quality based on semen analysis results prior to, and after taking the supplements.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Nov 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Nov 2023Dec 2026

First Submitted

Initial submission to the registry

June 5, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 8, 2022

Completed
1.4 years until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 8, 2025

Status Verified

August 1, 2024

Enrollment Period

3.2 years

First QC Date

June 5, 2022

Last Update Submit

April 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sperm Progressive Motility (Semen Analysis); as percentage (%)

    Semen analysis

    A repeat semen analysis will be performed 3 months after Power Prenatal for Sperm intervention

Secondary Outcomes (2)

  • Sperm Concentration (Semen Analysis); as millions / mL

    A repeat semen analysis will be performed 3 months after Power Prenatal for Sperm intervention

  • Sperm Morphology (Semen Analysis); as percentage (%)

    A repeat semen analysis will be performed 3 months after Power Prenatal for Sperm intervention

Study Arms (1)

Power Prenatal for Sperm

EXPERIMENTAL

This is a single arm study. Participants will take supplements for 3 months. The supplements is Power Prenatal for Sperm (active ingredients - https://birdandbe.com/the-power-prenatal-for-sperm)

Dietary Supplement: Power Prenatal for Sperm

Interventions

Power Prenatal for SpermDIETARY_SUPPLEMENT

A prenatal vitamin complex that includes numerous ingredients aim at improving sperm quality (ingredients: https://birdandbe.com/the-power-prenatal-for-sperm)

Also known as: Prenatal Vitamins
Power Prenatal for Sperm

Eligibility Criteria

Age18 Years - 45 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male
  • Age 18-45 years old
  • Experiencing infertility
  • A recent semen analysis confirming low count, motility or morphology (at least 1 of 3) - within last 3 months
  • Low concentration: \< 15 Million / mL
  • Low Motility: Progessive Motility \< 30%
  • Morphology: Strict criteria: Normal forms \< 4% Reference: WHO 2020 6th edition: https://www.who.int/publications/i/item/9789240030787

You may not qualify if:

  • No diagnosed varicocele
  • Younger than 18 years old
  • Older than 45 years old
  • Currently taking any form of antioxidant supplements(in last 3 months) besides a general multivitamin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reproductive Care Centre

Mississauga, Ontario, L5N 5S3, Canada

RECRUITING

MeSH Terms

Conditions

Infertility, Male

Interventions

Sperm CountPrenatal Care

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Cell CountCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisSemen AnalysisInvestigative TechniquesCell Physiological PhenomenaPatient CareTherapeuticsMaternal Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Dan Nayot, BSc, MSc, MD

    The Bird and Be Co

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dan Nayot, Bsc, MSc, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Patients with male factor infertility, who have a document abnormal semen analysis (at least 1 of 3 abnormal parameters - concentration, progressive motility or morphology) will be recruited to take a 3 month course of supplements (Power Prenatal for Sperm), and a repeat semen analysis will be performed after the intervention to compare results
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2022

First Posted

June 8, 2022

Study Start

November 1, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 8, 2025

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations